All articles by
US FDA clears Ligand’s Zelsuvmi for molluscum contagiosum treatment
The effectiveness of Zelsuvmi was proven in the B-SIMPLE 4 and B-SIMPLE 2 Phase 3 trials in which the drug, when taken once daily, was well tolerated and could lower lesion counts
Praxis Precision announces Licensing and Collaboration Agreement with Tenacia for Ulixacaltamide in Greater China
Collaboration leverages Tenacia’s expertise in central nervous system drug development and commercialization and will address a significant unmet patient need
AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure
GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic cardiomyopathy
Elevance Health to buy infusion services provider Paragon Healthcare
Paragon Healthcare, headquartered in Plano, Texas, offers infusion services to patients via its omnichannel model of ambulatory infusion centres, home infusion pharmacies, and other specialty pharmacy
HI-Bio Announces $95m Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases
Funding allows advancement of diverse programs through multiple clinical data readouts, including multiple indications for lead candidate felzartamab
Pfizer Canada gets Health Canada approval for Beqvez to treat haemophilia B
The approval was based on the open-label, single-arm Phase 3 BENEGENE-2 study in which a single dose of the therapy was found superior to the current standard of care
Esperion Therapeutics and Daiichi Sankyo Europe amend partnership
The amendment also consists of an amicable resolution to their commercial dispute and several other adjustments to improve the long-term value of their products
K Health Announces Collaboration with Mayo Clinic for Development of Cardiac Clinical AI Solution
K Health will work with Mayo Clinic to develop and test its bespoke preventative cardiology care technology
Cosette Pharmaceuticals Acquires Vyleesi from Palatin Technologies
Only FDA-Approved As-Needed Treatment For The Approximately 6 Million Premenopausal Women Who Suffer From Hypoactive Sexual Desire Disorder
SimBioSys, Mayo Clinic partner to develop AI-powered solutions for cancer patients
The collaboration is aimed at creating cloud-based clinical software tools that facilitate comprehensive decision-making for early-stage breast cancer patients